Partner Institutions

Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

• Harvard University, United States of America (USA)
• The University of Chicago (UChicago), United States of America (USA)
• German Cancer Research Center in the Helmholtz Association (DKFZ), Germany
• University of Southern California (USC), United States of America (USA)
• Fred Hutchinson Cancer Research Center (FHCRC), United States of America (USA)
• Stanford University, United States of America (USA)
• Vanderbilt University (VU), United States of America (USA)
• The University of Utah (Utah), United States of America (USA)
• NIH National Cancer Institute (NCI), United States of America (USA)
• Strangeways Research Laboratory, University of Cambridge, United Kingdom (UK)
• Wolfson Institute of Preventive Medicine, QMUL, United Kingdom (UK)
• Genetic Associations and Mechanisms in Oncology (GAME-ON), United States of America (USA)